Independent Work at WHU

Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer.

Date: 2023-08-16 Views: 451

Xiangping Deng, Xiaofei Deng, Wentao Ning, Lilan Xin, Qiuzi Li, Zhiye Hu, Baohua Xie, Kaiwei Liang,Chang Min, Chune Dong*, Jian Huang*, and Hai-Bing Zhou*

J. Med. Chem.2023,66,11094−11117.

Previous: Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer